(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.13%) $82.52
(0.54%) $2.04
(-0.55%) $2 344.80
(-1.10%) $27.36
(0.12%) $962.70
(0.11%) $0.933
(0.18%) $11.00
(0.05%) $0.796
(0.01%) $93.31
1.65% SEK 0.984
Live Chart Being Loaded With Signals
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study...
Stats | |
---|---|
Volumen de hoy | 19 004.00 |
Volumen promedio | 26 449.00 |
Capitalización de mercado | 35.36M |
EPS | SEK-0.192 ( 2023-11-08 ) |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.680 |
ATR14 | SEK0 (0.00%) |
Modus Therapeutics Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Modus Therapeutics Finanzas
Annual | 2023 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK0 (0.00 %) |
EPS: | SEK-1.010 |
FY | 2023 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK0 (0.00 %) |
EPS: | SEK-1.010 |
FY | 2022 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK0 (0.00 %) |
EPS: | SEK-1.140 |
FY | 2021 |
Ingresos: | SEK0.00 |
Beneficio Bruto: | SEK0.00 (0.00 %) |
EPS: | SEK-1.670 |
Financial Reports:
No articles found.
Modus Therapeutics
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico